These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19334421)

  • 21. Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.
    Cassinotti A; Actis GC; Duca P; Massari A; Colombo E; Gai E; Annese V; D'Albasio G; Manes G; Travis S; Porro GB; Ardizzone S
    Am J Gastroenterol; 2009 Nov; 104(11):2760-7. PubMed ID: 19623172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical treatment of ulcerative colitis. Some reflections.
    Banks C; Forbes A
    Dig Liver Dis; 2007 Apr; 39(4):338-41. PubMed ID: 17317345
    [No Abstract]   [Full Text] [Related]  

  • 23. Relationship between disease activity indices and colonoscopic findings in ulcerative colitis.
    Saddiq M; Hussain S; Farooq MA
    J Coll Physicians Surg Pak; 2003 Feb; 13(2):120. PubMed ID: 12685962
    [No Abstract]   [Full Text] [Related]  

  • 24. Ulcerative colitis with positivity for proteinase 3-antineutrophil cytoplasmic antibody.
    Suzuki K; Nakao S; Suzuki A; Inamori M; Iida H; Endo H; Akiyama T; Yoneda K; Fujita K; Takahashi H; Yoneda M; Abe Y; Kobayashi N; Kubota K; Saito S; Nakajima A
    Digestion; 2008; 77(3-4):157-8. PubMed ID: 18577854
    [No Abstract]   [Full Text] [Related]  

  • 25. Idiopathic pancreatitis associated with ulcerative colitis.
    Sáez J; Martínez J; García C; Griñó P; Pérez-Mateo M
    Am J Gastroenterol; 2000 Oct; 95(10):3004-5. PubMed ID: 11051402
    [No Abstract]   [Full Text] [Related]  

  • 26. Systemic hypersensitivity reaction to mesacol.
    Sule A; Gaitonde S; Bhojani K; Mittal G; Balakrishnan C; Gurmeet M; Deshpande RB; Joshi VR
    J Assoc Physicians India; 2001 Nov; 49():1120-2. PubMed ID: 11868872
    [No Abstract]   [Full Text] [Related]  

  • 27. [Professional and private loadable -- despite ulcerative colitis: With Mezavant 1 × daily noticeable therapeutic success ].
    Z Gastroenterol; 2015 May; 53(5):2 p following 523. PubMed ID: 26167555
    [No Abstract]   [Full Text] [Related]  

  • 28. Once-daily mesalamine (Lialda) for ulcerative colitis.
    Med Lett Drugs Ther; 2007 Mar; 49(1257):25-6. PubMed ID: 17375030
    [No Abstract]   [Full Text] [Related]  

  • 29. A systematic prospective comparison of noninvasive disease activity indices in ulcerative colitis.
    Turner D; Seow CH; Greenberg GR; Griffiths AM; Silverberg MS; Steinhart AH
    Clin Gastroenterol Hepatol; 2009 Oct; 7(10):1081-8. PubMed ID: 19577010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pemphigus vulgaris and ulcerative colitis.
    Kacar S; Sezgin O; Sahin T
    Am J Gastroenterol; 2002 Feb; 97(2):507-8. PubMed ID: 11866312
    [No Abstract]   [Full Text] [Related]  

  • 31. MLN-02 in IBD: is "super-selective" really super?
    Cohen RD
    Gastroenterology; 2006 May; 130(6):1923-4. PubMed ID: 16697759
    [No Abstract]   [Full Text] [Related]  

  • 32. The quantitative validation of non-endoscopic disease activity indices in ulcerative colitis.
    Higgins PD; Leung J; Schwartz M; Mapili J; Wren PA; Zimmermann EM
    Aliment Pharmacol Ther; 2007 Feb; 25(3):333-42. PubMed ID: 17269991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Encapsulated mesalamine granules (Apriso) for ulcerative colitis.
    Med Lett Drugs Ther; 2009 May; 51(1312):38-9. PubMed ID: 19448588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality of life in patients with active ulcerative colitis treated with selective leukocyte apheresis.
    Oxelmark L; Hillerås P; Dignass A; Mössner J; Schreiber S; Kruis W; Löfberg R
    Scand J Gastroenterol; 2007 Mar; 42(3):406-7. PubMed ID: 17354122
    [No Abstract]   [Full Text] [Related]  

  • 35. [Current diagnostic criteria of ulcerous colitis].
    Makarevich IaA
    Ter Arkh; 1971 Oct; 43(10):18-22. PubMed ID: 5316796
    [No Abstract]   [Full Text] [Related]  

  • 36. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis.
    D'Haens G; Sandborn WJ; Feagan BG; Geboes K; Hanauer SB; Irvine EJ; Lémann M; Marteau P; Rutgeerts P; Schölmerich J; Sutherland LR
    Gastroenterology; 2007 Feb; 132(2):763-86. PubMed ID: 17258735
    [No Abstract]   [Full Text] [Related]  

  • 37. [Patients need no longer plan meals. Colitis therapy is simplified].
    MMW Fortschr Med; 2002 Mar; 144(13):52. PubMed ID: 12001596
    [No Abstract]   [Full Text] [Related]  

  • 38. [Once daily mesalazine for long-term remission. Ulcerative colitis: maintenance therapy becomes easier].
    MMW Fortschr Med; 2008 Mar; 150(11):44-5. PubMed ID: 18447278
    [No Abstract]   [Full Text] [Related]  

  • 39. Collagenous colitis evolving into ulcerative colitis: a case report and review of the literature.
    Aqel B; Bishop M; Krishna M; Cangemi J
    Dig Dis Sci; 2003 Dec; 48(12):2323-7. PubMed ID: 14714620
    [No Abstract]   [Full Text] [Related]  

  • 40. Equimolar doses of balsalazide and mesalamine: are we comparing apples and oranges?
    Farrell RJ; Peppercorn MA
    Am J Gastroenterol; 2002 Jun; 97(6):1283-5. PubMed ID: 12094839
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.